Pediatric TransplantArchives
Liver transplantation for pediatric genetic and metabolic disorders.
Pediatric Transplant 1 min.
Pediatric genetic and metabolic liver diseases comprise a broad spectrum of conditions and represent the second most common indication for liver transplantation following biliary atresia. The decision to transplant can be challenging and requires consideration of several factors, including hepatic involvement,...
Balancing safety and effectiveness: parent preferences for fecal microbiota transplant and established therapies in pediatric inflammatory bowel disease-results of a multicenter Canadian study
Pediatric Transplant 1 min.
Treatment decision-making in pediatric inflammatory bowel disease (IBD) is complex, with many existing and emerging options. However, little is known about parent preferences for these therapies. This multi-center Canadian study provides the first quantitative data on parent preferences for pediatric...
Epidemiology of Invasive Fungal Disease in Pediatric Heart Transplant Recipients
Pediatric Transplant 1 min.
We describe the epidemiology of invasive fungal disease (IFD) in pediatric heart transplant recipients. Eight patients (4%) suffered IFD. Prolonged central access, delayed chest closure, broad-spectrum antibiotics, and extracorporeal membrane oxygenation (ECMO) were associated with early post-transplant...
The outcomes of isoniazid prophylaxis in LTBI high-risk pediatric patients undergoing hematopoietic stem cell transplantation
Pediatric Transplant 5 min.
Tuberculosis (TB) is a persistent global public health challenge, particularly in immunocompromised populations such as patients undergoing hematopoietic stem cell transplantation (HSCT) [1, 2]. The TB incidence in HSCT recipients is estimated to be 10–40 times higher than in the general population,...
